TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16958742

Group type: EXPERIMENTAL
Intervention: Thin probe (54 mm handle diameter)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Thick probe (92 mm handle diameter)
Number of subjects: 11
Study: 10482690

Group type: EXPERIMENTAL
Intervention: Ileocecal interpositional graft placement
Number of subjects: 14
Study: 8872417

Group type: EXPERIMENTAL
Intervention: 40 mg/day of tacrine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 80 mg/day of tacrine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tacrine (dosage not specified) with lecithin
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 1804294

Group type: EXPERIMENTAL
Intervention: Psoralen plus ultraviolet A (PUVA) therapy, oral psoralen (8‐methoxypsoralen; 0.6 mg/kg) taken at each session, 10-20 sessions 3 times per week
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Psoralen plus ultraviolet A (PUVA) therapy
Number of subjects: 83
Study: 6318347

Group type: EXPERIMENTAL
Intervention: Bi‐Profenid 150 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 31980156

Group type: EXPERIMENTAL
Intervention: Peri-hamstring local anaesthetic injection (Group H)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Anterior division obturator nerve block (Group O)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Adductor canal block alone (Group C)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: All groups (H, O, C)
Number of subjects: 105
Study: 30935601

Group type: EXPERIMENTAL
Intervention: Interactive power toothbrush (Oral-B Professional Care 6000, D36/EB20) with Bluetooth technology
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manual toothbrush (Oral-B Indicator 35 soft)
Number of subjects: 60
Study: 31185747

Group type: EXPERIMENTAL
Intervention: Use of personal technology (smartphones, internet, personal email)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Learning about HIV education via the internet
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Predictors of internet use for HIV prevention
Number of subjects: 320
Study: 26861604

Group type: EXPERIMENTAL
Intervention: FOLFOXIRI plus bevacizumab
Number of subjects: 374

Group type: COMPARATOR
Intervention: FOLFOXIRI
Number of subjects: 374
Study: 24886027

Group type: EXPERIMENTAL
Intervention: Developmentally Adapted Cognitive Processing Therapy (D-CPT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 90
Study: 22867036

Group type: COMPARATOR
Intervention: Placebo pill plus behavioral support
Number of subjects: 184
Study: 20168306

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (240 mg/day)
Number of subjects: 3069

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3069
Study: 18617314

Group type: EXPERIMENTAL
Intervention: 30:2 compression:ventilation (C:V) ratio
Number of subjects: 80

Group type: COMPARATOR
Intervention: 15:2 compression:ventilation (C:V) ratio
Number of subjects: 80
Study: 16143705

Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: atorvastatin 10 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: rosuvastatin 20 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: atorvastatin 20 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: rosuvastatin
Number of subjects: 100
Study: 12804793

Group type: EXPERIMENTAL
Intervention: Resistive viscous force field cued by blue color
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Assistive viscous force field cued by red color
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random presentation of two force fields
Number of subjects: 0
Study: 10574423

Group type: EXPERIMENTAL
Intervention: ramipril-felodipine ER (10/10 mg)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: ramipril-felodipine ER (5/5 mg)
Number of subjects: 507

Group type: COMPARATOR
Intervention: felodipine ER monotherapy
Number of subjects: 507
Study: 8834347

Group type: EXPERIMENTAL
Intervention: Unilateral airway occlusion at residual volume (RV)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Unilateral airway occlusion at total lung capacity (TLC)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Unilateral airway occlusion
Number of subjects: 8
Study: 1865280

Group type: EXPERIMENTAL
Intervention: alanine ORS
Number of subjects: 129

Group type: COMPARATOR
Intervention: WHO‐ORS
Number of subjects: 129
Study: 30336946

Group type: EXPERIMENTAL
Intervention: Volume‐controlled ventilation with inspiratory flow of 20 lpm (VC‐CMV20)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pressure support ventilation (PSV)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Target peak pressure of 40 cmH2O
Number of subjects: 30
Study: 28393853

Group type: EXPERIMENTAL
Intervention: Authentication of physical keys using optical multiple-scattering media and coherent states of light.
Number of subjects: 0
Study: 25304277

Group type: EXPERIMENTAL
Intervention: Subconjunctival preparation of 6×6 mm (group A)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Subconjunctival preparation of 8×9 mm (group B)
Number of subjects: 28
Study: 23150151

Group type: EXPERIMENTAL
Intervention: CYP2C19 loss-of-function alleles
Number of subjects: 670

Group type: COMPARATOR
Intervention: ABCB1 genotype
Number of subjects: 670

Group type: COMPARATOR
Intervention: PON1 genotype
Number of subjects: 670

Group type: COMPARATOR
Intervention: CYP2C19, ABCB1, and PON1 genotypes
Number of subjects: 670
Study: 21684018

Group type: EXPERIMENTAL
Intervention: Web-camera delivered cognitive-behavioral therapy (W-CBT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 31
Study: 20162114

Group type: EXPERIMENTAL
Intervention: BCP (biphasic calcium phosphate)
Number of subjects: 11

Group type: COMPARATOR
Intervention: DBB (deproteinized bovine bone)
Number of subjects: 11
Study: 18008156

Group type: EXPERIMENTAL
Intervention: Recombinant FSH commenced in the luteal phase with a long GnRH agonist protocol
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group received FSH on day 2 in a short protocol GnRH agonist regimen
Number of subjects: 42
Study: 15564545

Group type: EXPERIMENTAL
Intervention: Radial-artery grafts
Number of subjects: 561

Group type: COMPARATOR
Intervention: Saphenous-vein grafts
Number of subjects: 561
Study: 11278211

Group type: EXPERIMENTAL
Intervention: Ganirelix (0.25 mg, s.c.)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Triptorelin (0.1 mg, s.c.)
Number of subjects: 236
Study: 9466098

Group type: EXPERIMENTAL
Intervention: Alkalinized lignocaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Plain lignocaine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Alkalinized lignocaine and plain lignocaine
Number of subjects: 30
Study: 8192643

Group type: EXPERIMENTAL
Intervention: Depressed mood during initial exposure to spider stimuli
Number of subjects: 48

Group type: COMPARATOR
Intervention: Elated mood during initial exposure to spider stimuli
Number of subjects: 48
Study: 3075434

Group type: EXPERIMENTAL
Intervention: Ofloxacin (200 mg orally twice a day)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX) (160/800 mg orally twice a day)
Number of subjects: 56
Study: 31482359

Group type: EXPERIMENTAL
Intervention: Robotic-assisted laparoscopic surgery (RALS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Laparoscopic surgery (LS)
Number of subjects: 30
Study: 29266177

Group type: EXPERIMENTAL
Intervention: Secure priming
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Happy priming
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Neutral priming
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control conditions
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Attachment security
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Self-reported fear
Number of subjects: 90
Study: 28697910

Group type: EXPERIMENTAL
Intervention: Duphaston (20 mg/d)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Utrogestan (100 mg/d)
Number of subjects: 250
Study: 25577227

Group type: EXPERIMENTAL
Intervention: Conventional therapy (health education and tilt training) plus ORS (with 500 ml of water) - Group I (87 patients)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Conventional therapy - Group II (79 patients)
Number of subjects: 166
Study: 23720993

Group type: EXPERIMENTAL
Intervention: OPD-CA axis structure applied in clinical routine procedures
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: OPD-CA axis structure
Number of subjects: 42
Study: 21721447

Group type: EXPERIMENTAL
Intervention: Pipertaz
Number of subjects: 16

Group type: COMPARATOR
Intervention: Tazocin
Number of subjects: 16
Study: 18931845

Group type: EXPERIMENTAL
Intervention: Vitamin K Antagonist (VKA) for 30 months
Number of subjects: 34

Group type: COMPARATOR
Intervention: Discontinue Vitamin K Antagonist (VKA) after 6 months
Number of subjects: 34
Study: 16732017

Group type: EXPERIMENTAL
Intervention: Ramipril (1.25 mg o.d.)
Number of subjects: 4912

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4912
Study: 15353428

Group type: EXPERIMENTAL
Intervention: Faxed physician reminders containing osteoporosis treatment guidelines and patient education
Number of subjects: 102

Group type: COMPARATOR
Intervention: Usual care and information about falls and home safety
Number of subjects: 102
Study: 10755330

Group type: EXPERIMENTAL
Intervention: Extended-release oxybutynin 5 to 30mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extended-release oxybutynin 15mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate-release oxybutynin
Number of subjects: 0
Study: 9302787

Group type: EXPERIMENTAL
Intervention: Histamine provocation test
Number of subjects: 323

Group type: COMPARATOR
Intervention: PEF variability
Number of subjects: 323
Study: 8173166

Group type: EXPERIMENTAL
Intervention: Immediate platinum-based therapy
Number of subjects: 8000

Group type: EXPERIMENTAL
Intervention: Platinum in combination
Number of subjects: 8000

Group type: EXPERIMENTAL
Intervention: Carboplatin and cisplatin
Number of subjects: 8000
Study: 3669080

Group type: EXPERIMENTAL
Intervention: Marital therapy combined with symptom-specific therapy for sexual dysfunction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Relaxation and information before sex therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 0
Study: 31003664

Group type: EXPERIMENTAL
Intervention: Yoga nidra (1-hour sessions, bi-weekly for 8 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 28870177

Group type: EXPERIMENTAL
Intervention: Topical application of Tripterygium wilfordii Hook F gel
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study: 26305240

Group type: EXPERIMENTAL
Intervention: Single-sex after-school physical activity programs (PA)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Active comparison group (HL)
Number of subjects: 37
Study: 22406907

Group type: EXPERIMENTAL
Intervention: High protein diet (HP: 35% protein, 40% carbohydrate, 25% fat; 7,000 kJ/day)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard protein diet (SP: 17% protein, 58% carbohydrate, 25% fat; 7,000 kJ/day)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: High protein diet (HP)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard protein diet (SP)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 56
Study: 21777888

Group type: EXPERIMENTAL
Intervention: Bioresorbable Vascular Scaffolds (BVS)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Metallic Platform Stents (MPS)
Number of subjects: 161
Study: 19369231

Group type: EXPERIMENTAL
Intervention: Dasatinib 140 mg once daily
Number of subjects: 317

Group type: COMPARATOR
Intervention: Dasatinib 70 mg twice daily
Number of subjects: 317
Study: 17107493

Group type: EXPERIMENTAL
Intervention: Road traffic noise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meaningful irrelevant speech
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quiet control group
Number of subjects: 0
Study: 15363067

Group type: EXPERIMENTAL
Intervention: Recombinant human IGF‐I (0.05 mg/kg twice daily by subcutaneous injection)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Recombinant human IGF‐I
Number of subjects: 40
Study: 12577434

Group type: EXPERIMENTAL
Intervention: Jiechang Mixture (JCM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fungicidin (Control)
Number of subjects: 60
Study: 9700998

Group type: EXPERIMENTAL
Intervention: Cilnidipine (5 or 10 mg once daily)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Nifedipine retard (10 or 20 mg twice daily)
Number of subjects: 14
Study: 8090335

Group type: EXPERIMENTAL
Intervention: Diltiazem 0.3 mg/kg bolus preoperatively, followed by infusion of diltiazem 3 mg/kg/24 h preoperatively and oral diltiazem for 3 months
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo 0.3 mg/kg bolus preoperatively, followed by infusion of placebo 3 mg/kg/24 h preoperatively and oral placebo for 3 months
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 39
Study: 2670608

Group type: EXPERIMENTAL
Intervention: Chlorhexidine baths
Number of subjects: 64

Group type: COMPARATOR
Intervention: Non-medicated soap baths (Control)
Number of subjects: 64
Study: 1071632

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Triamterene
Number of subjects: 10
Study: 30317345

Group type: EXPERIMENTAL
Intervention: Closed method of pneumoperitonium (Group A)
Number of subjects: 850

Group type: COMPARATOR
Intervention: Open method of pneumoperitonium (Group B)
Number of subjects: 850
Study: 28271903

Group type: EXPERIMENTAL
Intervention: Corrective taping
Number of subjects: 18

Group type: COMPARATOR
Intervention: No tape
Number of subjects: 18
Study: 26506778

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba injection combined with traditional therapy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Traditional therapy (control group)
Number of subjects: 56
Study: 24001116

Group type: EXPERIMENTAL
Intervention: Multitarget stepping (MTS) program combined with a multicomponent exercise program
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 264
Study: 21263198

Group type: EXPERIMENTAL
Intervention: Thyroid suppression therapy with thyroxine (T4) 2.5µg/kg/day for two months
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (7 healthy women)
Number of subjects: 14
Study: 19055284

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Chinese drug (Wuzi Yanzong Pill)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Acupuncture plus medication
Number of subjects: 231
Study: 16224108

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation for 24 hours (n = 79)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Conventional management with oxygen therapy (control group, n = 83)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation in hypercapnic patients
Number of subjects: 162

Group type: COMPARATOR
Intervention: Conventional management in hypercapnic patients
Number of subjects: 162
Study: 12952258

Group type: EXPERIMENTAL
Intervention: AKITA system (inhalation device)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: PARI‐LC Star (inhalation device)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: HaloLite (inhalation device)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Prolastin (5% solution)
Number of subjects: 6
Study: 11071407

Group type: EXPERIMENTAL
Intervention: Radially expanding 10‐mm trocar
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional 10‐mm metal trocar
Number of subjects: 54
Study: 9118653

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Dobutamine plus norepinephrine
Number of subjects: 8
Study: 8458457

Group type: EXPERIMENTAL
Intervention: Follicular stimulation with hMG in insemination cycles
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Follicular stimulation with CC in insemination cycles
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Follicular stimulation with hMG in intercourse cycles
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Follicular stimulation with CC in intercourse cycles
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Insemination cycles
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Intercourse cycles
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: IUI and direct intraperitoneal insemination
Number of subjects: 148
Study: 3702643

Group type: EXPERIMENTAL
Intervention: Multiple vitamin, multiple mineral supplement containing 18 mg iron for 8 months
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 30043913

Group type: EXPERIMENTAL
Intervention: Vitamin D level (25(OH) vitamin D)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Age > 65 years
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vitamin D level cut-off
Number of subjects: 50
Study: 25932920

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Solifenacin 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24906584

Group type: EXPERIMENTAL
Intervention: 0.125% atropine eye drops plus auricular acupoint stimulation (0.125A + ACU group)
Number of subjects: 110

Group type: COMPARATOR
Intervention: 0.125% atropine alone (0.125A group)
Number of subjects: 110
Study: 24260145

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) for social anxiety disorder
Number of subjects: 314
Study: 20237361

Group type: EXPERIMENTAL
Intervention: High-dose extracorporeal shockwave therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intralesional corticosteroid injection
Number of subjects: 60
Study: 19009658

Group type: EXPERIMENTAL
Intervention: 2 g n‐3 polyunsaturated fatty acids (PUFA) from seal oils, three times a day, along with a recommended diet
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo, 2 g, three times a day, along with a recommended diet
Number of subjects: 144
Study: 16456383

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 22
Study: 12730769

Group type: COMPARATOR
Intervention: Strontium ranelate 2 g daily
Number of subjects: 9196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9196
Study: 10969106

Group type: EXPERIMENTAL
Intervention: Study fortifier (SF)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Commercial fortifier (CF)
Number of subjects: 144
Study: 8838764

Group type: EXPERIMENTAL
Intervention: Amniotic fluid endothelin-1 (ET-1) levels measured in aneuploid pregnancies
Number of subjects: 53

Group type: COMPARATOR
Intervention: Amniotic fluid endothelin-1 (ET-1) levels measured in euploid pregnancies
Number of subjects: 53
Study: 1332435

Group type: EXPERIMENTAL
Intervention: Amantadine hydrochloride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3523938

Group type: EXPERIMENTAL
Intervention: diethylstilbestrol (DES) or bilateral orchiectomy
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: cyclophosphamide plus 5‐fluorouracil plus DES
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: estramustine phosphate (Emcyt)
Number of subjects: 319
Study: 29902226

Group type: EXPERIMENTAL
Intervention: Dopaminergic modulation during incidental learning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25796103

Group type: EXPERIMENTAL
Intervention: Intervention Group (n = 14) received 1.7 g protein/kg/day during admission and a daily protein supplement (18.8 g protein) and resistance training 3 times per week for 12 weeks after discharge
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control Group (n = 15)
Number of subjects: 29
Study: 23857507

Group type: EXPERIMENTAL
Intervention: Adefovir + telbivudine (group 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adefovir followed by adefovir + telbivudine (group 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lamivudine + adefovir followed by adefovir + telbivudine (group 3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telbivudine treatment
Number of subjects: 0
Study: 22784897

Group type: EXPERIMENTAL
Intervention: Mini-midvastus approach (MMV group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medial parapatellar approach (MPP group)
Number of subjects: 60
Study: 20575712

Group type: EXPERIMENTAL
Intervention: Carraguard gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 0
Study: 18177949

Group type: EXPERIMENTAL
Intervention: Vitamin D intervention, specific dosage and duration not available
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control, specific details not available
Number of subjects: 0
Study: 16827627

Group type: EXPERIMENTAL
Intervention: Coping improvement group intervention (12 sessions delivered via teleconference)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Delayed treatment (control group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Coping improvement group intervention
Number of subjects: 90
Study: 12793558

Group type: EXPERIMENTAL
Intervention: Early ambulation (group A)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Bed rest (group B)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Overall headache reporting
Number of subjects: 207
Study: 9917782

Group type: EXPERIMENTAL
Intervention: Topical anesthesia plus intracameral 1% preservative-free lidocaine
Number of subjects: 68

Group type: COMPARATOR
Intervention: Intracameral balanced salt solution
Number of subjects: 68
Study: 7571782

Group type: EXPERIMENTAL
Intervention: Balloon angioplasty
Number of subjects: 15000

Group type: COMPARATOR
Intervention: Alternative devices (excimer laser, rotablator, directional atherectomy, stents)
Number of subjects: 15000
Study: 2182208

Group type: EXPERIMENTAL
Intervention: Lidocaine treatment (100 mg bolus followed by 2 mg.kg-1 for at least the first 24 hours)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 83
Study: 99690

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Imipramine (open trial)
Number of subjects: 10